[Treatment of malaria: prevention of resistance by combinations of antimalarial agents].
Ambroise-Thomas
P
P
Service des Interactions Cellulaires Parasite-Hôte (ICPH), Faculté de Médecine, EA-UJF 2940 ER-CNRS 2014, Université Joseph Fourier, 38043 Grenoble Cedex 07, France. PAmbroise-Thomas@chu-grenoble.fr
D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage* / Q000627:therapeutic use; D000077549:Artemether; D037621:Artemisinins; D000077332:Artesunate; D004351:Drug Resistance / Q000235:genetics; D004359:Drug Therapy, Combination; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D015767:Mefloquine / Q000008:administration & dosage; D009287:Naphthyridines / Q000008:administration & dosage; D010961:Plasmodium / Q000187:drug effects / Q000235:genetics; D012717:Sesquiterpenes / Q000008:administration & dosage
D000962:Antimalarials; D037621:Artemisinins; D009287:Naphthyridines; D012717:Sesquiterpenes; D000077332:Artesunate; D000077549:Artemether; C027871:pyronaridine; D015767:Mefloquine